| Literature DB >> 31482584 |
Mustafa Ghanbarabadi1, Farahnaz Falanji1, Abolfazl Rad2, Nafiseh Chazani Sharahi1, Sakineh Amoueian3, Mohamadreza Amin4, Mehdi Molavi5, Bahareh Amin6.
Abstract
We investigated whether clavulanic acid could improve learning and memory, in rats underwent bilateral occlusion of common carotid artery (2VO). Seventy male Wistar rats were subjected to 2VO, with a 1-week interval between right and left artery occlusions. After 2VO, animals received clavulanic acid (10, 20, 40 mg/kg, intraperitoneally), from day 8 to 20. Spatial memory was assessed in the Morris water maze, 1 week after the induction of 2VO (day 15). The mRNA expression levels of bcl-2, bcl2-associated x protein (bax), caspase-3, inducible nitric oxide synthase (iNOS), and amyloid beta precursor protein (APP) were measured in the neocortex and hippocampus. Clavulanic acid significantly decreased the escape latency and swimming time in the training trial days. As well, it increased time and distance percentage in the target quadrant, while it decreased such factors in the opposite quadrant in the final trial day, compared to 2VO + normal saline animals. Real time-PCR data showed a significant higher mRNA expression of bax, caspase 3, and iNOS in the hippocampus and neocortex of 2VO animal compared to nonoccluded rats. APP increased in the neocortex but not hippocampus. Compared with 2VO animals, clavulanic acid significantly down-regulated the expression of iNOS, caspase 3, and APP, accompanied by diminishing the bax/bcl2 ratio. Our results reveal a potential therapeutic use of clavulanic acid for cognitive dysfunction associated with cerebral hypoperfusion in vascular dementia and Alzheimer disease.Entities:
Keywords: Alzheimer's disease; amyloid precursor protein; apoptosis; clavulanic acid; common carotid artery occlusion; nitrosative stress
Mesh:
Substances:
Year: 2019 PMID: 31482584 DOI: 10.1002/ddr.21595
Source DB: PubMed Journal: Drug Dev Res ISSN: 0272-4391 Impact factor: 4.360